2025-04-01 2026-03-31 2026-03-31 false 15000404 SSRS Healthcare Ltd 2026-07-27 false iso4217:GBP xbrli:pure 15000404 2025-03-31 15000404 2026-03-31 15000404 2025-04-01 2026-03-31 15000404 2024-03-31 15000404 2025-03-31 15000404 2024-04-01 2025-03-31 15000404 bus:SmallEntities 2025-04-01 2026-03-31 15000404 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 15000404 bus:FullAccounts 2025-04-01 2026-03-31 15000404 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15000404 core:WithinOneYear 2026-03-31 15000404 core:AfterOneYear 2026-03-31 15000404 core:WithinOneYear 2025-03-31 15000404 core:AfterOneYear 2025-03-31 15000404 core:ShareCapital 2026-03-31 15000404 core:SharePremium 2026-03-31 15000404 core:RevaluationReserve 2026-03-31 15000404 core:OtherReservesSubtotal 2026-03-31 15000404 core:RetainedEarningsAccumulatedLosses 2026-03-31 15000404 core:ShareCapital 2025-03-31 15000404 core:SharePremium 2025-03-31 15000404 core:RevaluationReserve 2025-03-31 15000404 core:OtherReservesSubtotal 2025-03-31 15000404 core:RetainedEarningsAccumulatedLosses 2025-03-31 15000404 core:LandBuildings 2026-03-31 15000404 core:PlantMachinery 2026-03-31 15000404 core:Vehicles 2026-03-31 15000404 core:FurnitureFittings 2026-03-31 15000404 core:OfficeEquipment 2026-03-31 15000404 core:NetGoodwill 2026-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 15000404 core:ListedExchangeTraded 2026-03-31 15000404 core:UnlistedNon-exchangeTraded 2026-03-31 15000404 core:LandBuildings 2025-03-31 15000404 core:PlantMachinery 2025-03-31 15000404 core:Vehicles 2025-03-31 15000404 core:FurnitureFittings 2025-03-31 15000404 core:OfficeEquipment 2025-03-31 15000404 core:NetGoodwill 2025-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 15000404 core:ListedExchangeTraded 2025-03-31 15000404 core:UnlistedNon-exchangeTraded 2025-03-31 15000404 core:LandBuildings 2025-04-01 2026-03-31 15000404 core:PlantMachinery 2025-04-01 2026-03-31 15000404 core:Vehicles 2025-04-01 2026-03-31 15000404 core:FurnitureFittings 2025-04-01 2026-03-31 15000404 core:OfficeEquipment 2025-04-01 2026-03-31 15000404 core:NetGoodwill 2025-04-01 2026-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 15000404 core:ListedExchangeTraded 2025-04-01 2026-03-31 15000404 core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 15000404 core:MoreThanFiveYears 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments 2026-03-31 15000404 core:Non-currentFinancialInstruments 2025-03-31 15000404 dpl:CostSales 2025-04-01 2026-03-31 15000404 dpl:DistributionCosts 2025-04-01 2026-03-31 15000404 core:LandBuildings 2025-04-01 2026-03-31 15000404 core:PlantMachinery 2025-04-01 2026-03-31 15000404 core:Vehicles 2025-04-01 2026-03-31 15000404 core:FurnitureFittings 2025-04-01 2026-03-31 15000404 core:OfficeEquipment 2025-04-01 2026-03-31 15000404 dpl:AdministrativeExpenses 2025-04-01 2026-03-31 15000404 core:NetGoodwill 2025-04-01 2026-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 15000404 dpl:GroupUndertakings 2025-04-01 2026-03-31 15000404 dpl:ParticipatingInterests 2025-04-01 2026-03-31 15000404 dpl:GroupUndertakings core:ListedExchangeTraded 2025-04-01 2026-03-31 15000404 core:ListedExchangeTraded 2025-04-01 2026-03-31 15000404 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 15000404 core:UnlistedNon-exchangeTraded 2025-04-01 2026-03-31 15000404 dpl:CostSales 2024-04-01 2025-03-31 15000404 dpl:DistributionCosts 2024-04-01 2025-03-31 15000404 core:LandBuildings 2024-04-01 2025-03-31 15000404 core:PlantMachinery 2024-04-01 2025-03-31 15000404 core:Vehicles 2024-04-01 2025-03-31 15000404 core:FurnitureFittings 2024-04-01 2025-03-31 15000404 core:OfficeEquipment 2024-04-01 2025-03-31 15000404 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 15000404 core:NetGoodwill 2024-04-01 2025-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 15000404 dpl:GroupUndertakings 2024-04-01 2025-03-31 15000404 dpl:ParticipatingInterests 2024-04-01 2025-03-31 15000404 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 15000404 core:ListedExchangeTraded 2024-04-01 2025-03-31 15000404 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 15000404 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 15000404 core:NetGoodwill 2026-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 15000404 core:LandBuildings 2026-03-31 15000404 core:PlantMachinery 2026-03-31 15000404 core:Vehicles 2026-03-31 15000404 core:FurnitureFittings 2026-03-31 15000404 core:OfficeEquipment 2026-03-31 15000404 core:AfterOneYear 2026-03-31 15000404 core:WithinOneYear 2026-03-31 15000404 core:ListedExchangeTraded 2026-03-31 15000404 core:UnlistedNon-exchangeTraded 2026-03-31 15000404 core:ShareCapital 2026-03-31 15000404 core:SharePremium 2026-03-31 15000404 core:RevaluationReserve 2026-03-31 15000404 core:OtherReservesSubtotal 2026-03-31 15000404 core:RetainedEarningsAccumulatedLosses 2026-03-31 15000404 core:NetGoodwill 2025-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 15000404 core:LandBuildings 2025-03-31 15000404 core:PlantMachinery 2025-03-31 15000404 core:Vehicles 2025-03-31 15000404 core:FurnitureFittings 2025-03-31 15000404 core:OfficeEquipment 2025-03-31 15000404 core:AfterOneYear 2025-03-31 15000404 core:WithinOneYear 2025-03-31 15000404 core:ListedExchangeTraded 2025-03-31 15000404 core:UnlistedNon-exchangeTraded 2025-03-31 15000404 core:ShareCapital 2025-03-31 15000404 core:SharePremium 2025-03-31 15000404 core:RevaluationReserve 2025-03-31 15000404 core:OtherReservesSubtotal 2025-03-31 15000404 core:RetainedEarningsAccumulatedLosses 2025-03-31 15000404 core:NetGoodwill 2024-03-31 15000404 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 15000404 core:LandBuildings 2024-03-31 15000404 core:PlantMachinery 2024-03-31 15000404 core:Vehicles 2024-03-31 15000404 core:FurnitureFittings 2024-03-31 15000404 core:OfficeEquipment 2024-03-31 15000404 core:AfterOneYear 2024-03-31 15000404 core:WithinOneYear 2024-03-31 15000404 core:ListedExchangeTraded 2024-03-31 15000404 core:UnlistedNon-exchangeTraded 2024-03-31 15000404 core:ShareCapital 2024-03-31 15000404 core:SharePremium 2024-03-31 15000404 core:RevaluationReserve 2024-03-31 15000404 core:OtherReservesSubtotal 2024-03-31 15000404 core:RetainedEarningsAccumulatedLosses 2024-03-31 15000404 core:AfterOneYear 2025-04-01 2026-03-31 15000404 core:WithinOneYear 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:CostValuation 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-04-01 2026-03-31 15000404 core:Non-currentFinancialInstruments core:CostValuation 2026-03-31 15000404 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-03-31 15000404 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 15000404 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 15000404 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 15000404 bus:Director1 2025-04-01 2026-03-31

SSRS Healthcare Ltd

Registered Number
15000404
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

SSRS Healthcare Ltd
Company Information
for the year from 1 April 2025 to 31 March 2026

Director | Dr Sammy Sarai

Registered Address | Fulford Lodge 1 Heslington Lane
| Fulford
| York
| YO10 4HW

Registered Number | 15000404 (England and Wales)

SSRS Healthcare Ltd
Statement of Financial Position
31 March 2026

| Notes | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 4,292 |  |  |  | 3,947
|  |  |  | 4,292 |  |  |  | 3,947
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 3,006 |  |  |  | 10,062 |  |
Cash at bank and on hand |  | 50,642 |  |  |  | 36,502 |  |
|  | 53,648 |  |  |  | 46,564 |  |
Creditors amounts falling due within one year | 5 | (18,236) |  |  |  | (19,094) |  |
Net current assets (liabilities) |  |  |  | 35,412 |  |  |  | 27,470
Total assets less current liabilities |  |  |  | 39,704 |  |  |  | 31,417
Net assets |  |  |  | 39,704 |  |  |  | 31,417
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 39,604 |  |  |  | 31,317
Shareholders' funds |  |  |  | 39,704 |  |  |  | 31,417

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 27 July 2026, and are signed on its behalf by:
Dr Sammy Sarai Director Registered Company No. 15000404

SSRS Healthcare Ltd
Notes to the Financial Statements
for the year ended 31 March 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.

| Basis of preparation
--- | ---
| The financial statements have been prepared on the historical cost basis.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling, which is the functional currency of the entity.

| Going concern
--- | ---
| The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.

| Turnover policy
--- | ---
| The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.

| Current taxation
--- | ---
| The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.

| Tangible fixed assets and depreciation
--- | ---
| Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

|  | Reducing balance (%)
| Plant and machinery | 20
| Office Equipment | 20

| Trade and other debtors
--- | ---
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

| Trade and other creditors
--- | ---
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

| Share capital
--- | ---
| Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.

2. | Average number of employees
--- | ---

|  | 2026 |  | 2025
| Average number of employees during the year | 1 |  | 1

3. | Tangible fixed assets
--- | ---

|  | Plant & machinery |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| At 01 April 25 | 4,144 |  | 790 |  | 4,934
| Additions | 219 |  | 1,199 |  | 1,418
| At 31 March 26 | 4,363 |  | 1,989 |  | 6,352
| Depreciation and impairment
| At 01 April 25 | 829 |  | 158 |  | 987
| Charge for year | 707 |  | 366 |  | 1,073
| At 31 March 26 | 1,536 |  | 524 |  | 2,060
| Net book value
| At 31 March 26 | 2,827 |  | 1,465 |  | 4,292
| At 31 March 25 | 3,315 |  | 632 |  | 3,947

4. | Debtors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 3,006 |  | 8,562
| Prepayments and accrued income | - |  | 1,500
| Total | 3,006 |  | 10,062

5. | Creditors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 308 |  | -
| Taxation and social security | 15,585 |  | 16,553
| Other creditors | 323 |  | 1,111
| Accrued liabilities and deferred income | 2,020 |  | 1,430
| Total | 18,236 |  | 19,094

6. | Related party transactions
--- | ---
| During the year, the director loaned the company £323 (2025: £1,111). Interest was accrued on the loan balance each month and applied at the UK market rate. This loan is repayable upon demand.